Table 2 Therapeutic response of patients with breast cancer after neoadjuvant chemotherapy (NACT) in patients with breast cancer.
From: Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
Therapeutic responses | After NACT (n = 134) |
|---|---|
Tumor diameter, cm | 1.60 ± 0.64** |
Complete remission, n (%) | 50 (37.3) |
Partial remission, n (%) | 44 (32.9) |
Stable disease, n (%) | 34 (25.7) |
Progression disease, n (%) | 5(4.3) |
Total, n (%) | 94 (70.0) |
